# A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication

> **NCT01488071** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 495 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Vortioxetine (Lu AA21004)
- **DRUG:** Agomelatine

## Key facts

- **NCT ID:** NCT01488071
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-12
- **Final completion:** —
- **Target enrollment:** 495 (ACTUAL)
- **Last updated:** 2014-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01488071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01488071, "A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01488071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
